KAWASAKI'S SYNDROME

  •  

    KAWASAKI'S SYNDROME

     

    DEFINITION:

    A vasculitic syndrome of large-medium vessels classically characterized as an acute febrile illness associated with a systemic vasculitis.

    EPIDEMIOLOGY:

    • incidence: 1-10/100,000
    • age of onset:
      • peak age is 1-3 years
      • 80-85% <5 years; seldom >7 years; rare >11 years
    • risk factors:
      • M > F (1.5:1)
      • endemic but increased in late winter to early spring
      • seasonal epidemics every 2-3 years
      • Orientals > Blacks > Whites
      • secondary case contacts are rare (<1% to 2.1%)
      • increased risk in a sibling (2.1% vs 0.19%) and in 54% of these cases, the illness occurs within 10 days of onset in the 1st
      • only 2-3% recurrence rate

    PATHOGENESIS:

    1. Etiology

    • expression of the syndrome seems to be dependent upon a susceptible host being exposed to specific triggers:

    1. Genetic Predisposition (Susceptible Host)

    • Orientals > Blacks > Whites
    • ? HLA-Bw22

    2. Specific Triggers

    1. Post-Infectious

    • bacterial - Strep. sanguis, Proprionibacterium acnes
    • viral - retrovirus

    CLINICAL FEATURES:

    1. Principal Symptoms

  • 1. Fever (persisting 5 days or more)
  • 2. Bilateral Conjunctival Exanthema
  • 3. Oral Mucosal Changes
  • 4. Cervical Lymphadenopathy
  • 5. Peripheral Extremity Changes
    • Acute Stage
    • Subacute Stage
  • 6. Polymorphous Rash
  • Note: 5/6 criteria needed for "typical" diagnosis and 3/6 criteria for "atypical" diagnosis

    2. Stages (3)

    1. Acute

    • from onset of symptoms til resolution of fever
    • lasts from 5 to 21 days (mean = 11 days)

    1. Fever

    • earliest symptom
    • remittent (39.5-40.5 C), high spiking, prolonged
    • does not respond to antibiotic therapy
    • resolves within 2-3 days of starting high dose ASA

    2. Bilateral Conjunctival Exanthem

    • begins shortly after onset of fever, lasts 1-2 weeks
    • bulbar conjunctivitis with vascular dilation but no exudate or palpebral involvement

    3. Oral Mucosal Changes

    • red, swollen, dry, fissured lips
    • "strawberry tongue"
    • diffuse erythema of oral & pharyngeal mucosa

    4. Cervical Lymphadenopathy

    • posterior cervical lymphadenopathy (50-75%)
    • acute and nonpurulent; at least one node >1.5 cm
    • tender, rarely red, fluctuant, torticollis

    5. Peripheral Extremity Changes (acute stage)

    • reddening of palms and soles
    • indurative edema & tenderness of hands and feet

    6. Polymorphous Rash

    • begins within 5 days after onset of fever
    • fine, erythematous, morbilliform generalized rash
    • intense, desquamating rash in perineum (25-50%)

    2. Subacute

    • from resolution of fever to disappearance of all clinical symptoms
    • occurs by the 3rd to 4th week after onset
    • lasts for 2 to 4 weeks

    1. Peripheral Extremity Changes (subacute stage)

    • membranous desquamation of fingertips & toetips
    • noted at days 10-20 after onset of fever
    • Beau's lines - deep transverse grooves across nails

    3. Convalescent

    • ends when the ESR & platelet count return to normal
    • usually lasts 10 to 12 weeks

    3. Complications

    1. Neurological Manifestations

    • extreme irritability and lethargy
    • aseptic meningitis (25%) +\- meningismus
    • hemiparesis or paralysis of extremities, ataxia
    • pseudotumor cerebri
      • increased intracranial pressure with papilledema
      • cranial nerve and facial palsies; seizures
    • mild sensorineuronal hearing loss

    2. Respiratory Manifestations

    • tympanitis
    • rhinorrhea
    • pneumonitis, pneumonia or pleural effusion

    3. Cardiovascular Manifestations (20%)

    1. Acute Stage (within first 10 days of onset of fever)

    1. Myocarditis/Endocarditis
    • arrhythmias, gallop rhythm, CHF with shock
    2. Pericarditis
    • pericardial effusion
    • cardiac tamponade (Beck's Triad - hypotension, distended neck veins, diminished heart sounds)
    3. Mitral/Aortic Regurgitation
    • murmers, congestive heart failure (CHF)

    2. Subacute Stage

    1. Coronary Artery Vasculitis
    • dilatation +/- aneurysms (20-40%)
      • first detected at a mean of 10 days
      • peak occurrence at 3-4 weeks after onset
      • very rare to occur after 4 weeks
      • 50% of aneurysms resolve by 18 months
    • thrombosis and stenotic lesions -> angina, MI
    • ruptured coronary aneurysm -> hemopericardium
    2. Systemic Vasculitis (1-2%)
    • cerebral vasculitis
    • aneurysms of subclavian, axillary, brachial, and/or hepatic arteries
    • peripheral ischemia of hands & feet -> gangrene

    4. Gastrointestinal Manifestations

    • abdominal pain
    • diarrhea
    • hepatitis
    • hydrops of gall bladder (5%)
    • mild obstructive jaundice
    • nausea/vomiting
    • paralytic ileus
    • RUQ mass or fullness

    5. Genitourinary Manifestations

    • priapism
    • proteinuria
    • hematuria with interstitial nephritis
    • pyuria
    • urethritis

    6. Musculoskeletal Manifestatons

    1. Arthritis/Arthralgia (up to 30%)

    1. Acute
    • polyarticular: knees, ankles, hands
    • onset 1st week & lasts for 3 weeks
    2. Subacute
    • pauciarticular: weight-bearing joints
    • onset 2nd-3rd week & lasts for 2-12 weeks

    7. Others

    • ocular - mild anterior uveitis (80%)

    INVESTIGATIONS:

    1. Serum

    1. Acute Phase Reactants

    • increased ESR & alpha-1 antitrypsin, positive CRP
    • elevated at onset of fever and persists for 6-10 weeks

    2. CBC

    • anemia - mild-moderate normochromic normocytic
      • resolves during convalescent phase
    • thrombocytosis - normal during 1st week, increases during 2nd week, peaks at 3 weeks
    • leukocytosis - mild-moderate (12-18) but as high as 30
      • predominance of neutrophils
      • left shift with increase in bands

    3. Others

    • hypoalbuminemia (as low as 20 g/L)
    • normal immunoglobulins, C3, C4, elevated IgE
    • positive circulating immune complexes
    • negative cultures, serologic assays, ANA, Rf
    • liver function tests - mildly to moderately elevated

    2. CSF

    1. Aseptic Meningitis

    • mononuclear pleocytosis (25-100 WBC)
    • normal or slightly elevated protein
    • normal glucose

    3. EKG

    • arrhythmias - 1st & 2nd degree heart block, PVC, prolonged QT interval, non-specific ST-T segment changes

    4. Urinalysis

    • pyuria, microscopic hematuria
    • minimal proteinuria

    5. Imaging Studies

    1. 2D-Echo

    • at 3-4 weeks then again at 6-8 weeks after onset

    2. Coronary Angiograms

    • to detect impaired perfusion from coronary stenosis or thrombosis

    MANAGEMENT:

    1. Acute Phase

    1. Supportive

    • hydration therapy if dehydrated
    • pain control

    2. Medications

    1. Gammaglobulin (IVGG)

    • 2 gm/kg IV in one infusion

    2. High Dose ASA

    • 100 mg/kg/day po qid until afebrile for 24-36 hours
    • institution of IVGG and ASA within 10 days of fever onset reduces the incidence of coronary artery lesions from 18% to 4%

    2. Subacute Phase

    1. Low Dose ASA

    • 3-5 mg/kg/day po od
      • begin after afebrile for 24-36 hours
      • no cardiac involvement
      • continue until ESR and platelet count are normal (6-8 weeks) or 2D Echo normal at 8 weeks

     

     

    Pediatric Database - KAWASAKI'S SYNDROME

    Pediatric Organization - Pedbase [at] Gmail.com